⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL125458 | 0.76 | — | — | |
| SCHEMBL14362697 | 0.72 | — | — | |
| SCHEMBL979771 | 0.67 | — | — | |
| SCHEMBL12038695 | 0.67 | CA1 (0.45) | — | |
| SCHEMBL12557311 | 0.67 | — | — | |
| SCHEMBL1809246 | 0.67 | — | — | |
| SCHEMBL13465286 | 0.67 | — | — | |
| SCHEMBL5747706 | 0.67 | — | — | |
| SCHEMBL14791365 | 0.67 | — | — | |
| SCHEMBL9697862 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| US-20190177862-A1 | HYDROGEN UTILIZATION AND CARBON RECOVERY | COORSTEK, INC. | 2019-06-13 | — | — | US | claimed |
| EP-3039099-B1 | METHOD FOR UPGRADING BIOMASS MATERIAL | COORSTEK INC (US) | 2019-06-12 | — | — | EP | claimed |
| EP-3039099-A1 | HYDROGEN UTILIZATION AND CARBON RECOVERY | Ceramatec, Inc (US) | 2016-07-06 | — | — | EP | claimed |
| US-20150060296-A1 | Hydrogen Utilization and Carbon Recovery | COORSTEK, INC. | 2015-03-05 | — | — | US | claimed |
| WO-2015031889-A1 | HYDROGEN UTILIZATION AND CARBON RECOVERY | CERAMATEC, INC. (US) | 2015-03-05 | — | — | WO | claimed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| EP-0534907-B1 | The use of furanone derivatives for the prevention or treatment of autoimmune diseases | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1998-08-05 | — | — | EP | claimed |
| US-5532271-A | TREATMENT OF RHEUMATOID ARTHRITIS, MULTIPLE SCLEROSIS, ENCEPHALOMYELITIS, HEMOLYTIC ANEMIA | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | claimed |
| US-5376682-A | Autoimmune diseases | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1994-12-27 | — | — | US | claimed |
| EP-0534907-A1 | The use of furanone derivatives for the prevention or treatment of autoimmune diseases | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1993-03-31 | — | — | EP | claimed |
| EP-0152027-B1 | PROCESS FOR THE PREPARATION OF 3-METHYL-2-BUTEN-4-OLIDE(4-METHYL-2-(5H)-FURAN-2-ONE) | Studiengesellschaft Kohle mbH (DE) | 1990-04-11 | — | — | EP | claimed |
| US-4659843-A | Process for preparing 3-methyl-2-butene-4-olide (4-methyl-2(5H)-furane-2-one) | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1987-04-21 | — | — | US | claimed |
| EP-0152027-A2 | Process for the preparation of 3-methyl-2-buten-4-olide(4-methyl-2-(5H)-furan-2-one) | Studiengesellschaft Kohle mbH (DE) | 1985-08-21 | — | — | EP | claimed |
| JP-7196491-A | — | — | None | — | — | JP | disclosed |
| US-3970706-A | MULTISTAGE | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1976-07-20 | — | — | US | disclosed |